Godavari Drugs shares closed at 90.00 on February 14, 2025 (BSE) and has given -12.32% returns over the last 6 months and -10.20% over last 12 months. Reported Standalone quarterly numbers for Godavari drugs are: Net Sales at Rs 29.55 crore in December 2024 down 31.45% from Rs. 43.11 crore in Dec 2023. Net Profit at Rs. 0.77 crore inDec 2024 down 37.14% from. Rs. 1.22 crore indec 2023; EBITDA stands at. 2.67 crore inDecember 2024 down 25.21% from £3.57 crore in DEC 2023, and EPS has decreased to Rs.1.02 inDec 2023 from £1.62 in Dec2023. Shareholding: Pledged/Encumbered – Number of shares (Crores) — — — – Per. of Shares (as a % of the total sh. of prom. and promoter group) — — — – per. share of the company. Non-encumbered — Number of. shares (crores) (as % of total Share Cap. of company) —- — — Per. shareholding (as% of total share cap. of firm) –— — — per share of firm.
